Clinical Trials Logo

Steroid-Induced Glaucoma clinical trials

View clinical trials related to Steroid-Induced Glaucoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT04673201 Recruiting - Clinical trials for Steroid-Induced Glaucoma

Management Steroid Induced Glaucoma

Start date: November 21, 2020
Phase: N/A
Study type: Interventional

Purpose: To assess the safety and efficacy of Viscotrabeculotomy Versus trabeculectomy with MMC for the management of medically uncontrolled steroid induced glaucoma. Patients and methods: A retrospective review of 86 eyes of 67 patients with medically uncontrolled SIG who underwent either viscotrabeculotomy (VT) or trabeculectomy with MMC (Trab-MMC) at Mansoura Ophthalmic Center (Mansoura, Egypt) between January 2008, and December 2017 was conducted. Keywords: Steroid induced glaucoma, trabeculectomy, trabeculotomy and MMC.

NCT ID: NCT04593745 Recruiting - ALL, Childhood Clinical Trials

Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids

ALL
Start date: July 9, 2018
Phase: N/A
Study type: Interventional

Childhood ALL patients are treated with high dose steroids. The study will follow the intraocular pressure of children treated in according to an AIEOP-BFM protocol, during the induction phase that will be compared to the pressure before treatment. Potential risk factors for developing elevated intraocular pressure will be estimated.

NCT ID: NCT04075227 Completed - Clinical trials for Steroid-Induced Glaucoma

Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

Start date: October 16, 2015
Phase: Phase 4
Study type: Interventional

The objective of this study was to evaluate the efficacy of topical 0.2% loteprednol etabonate, a 'soft steroid', compared with topical 0.1% dexamethasone, which is widely used in postoperative pterygium excision to prevent the recurrence of pterygium. If 0.2% loteprednol etabonate is non-inferior in efficacy compared with 0.1% dexamethasone, it may be used postoperatively in pterygium excision patients with the benefit of a low incidence of ocular hypertension or secondary glaucoma.

NCT ID: NCT01912638 Completed - Clinical trials for Steroid Induced Glaucoma

Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma

Start date: July 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this prospective randomized study is to assess and compare the clinical efficacy and safety of primary trabeculectomy with Ologen® collagen implant and cohesive viscoelastic (Provisc®) - augmented trabeculectomy in patients with medically uncontrolled steroid induced glaucoma.